##plugins.themes.academic_pro.article.main##

Abstract

The vast majority of the lesions that occur in the breast are benign. Much concern is given to malignant lesions of the breast because breast cancer is the most common malignancy in women in Western countries; however, benign lesions of the breast are far more frequent than malignant ones .With the use of mammography, ultrasound, and magnetic resonance imaging of the breast and the extensive use of needle biopsies, the diagnosis of a benign breast disease can be accomplished without surgery in the majority of patients. Because the majority of benign lesions are not associated with an increased risk for subsequent breast cancer, unnecessary surgical procedures should be avoided The objective of this study is to: 1. Evaluate the benign breast disease in Balad city and its percentage. 2. Advice those women who need fallow up if there is risk of cancer

Keywords

Breast disease benign breast disease breast lesions and follow up

##plugins.themes.academic_pro.article.details##

How to Cite
Hussein Sahan Jasim, Lateef Naif Razeek, & Esam Abdalhameed Hasan. (2022). Benign Breast Disease Is Need Follow Up?. Texas Journal of Medical Science, 4, 4–11. https://doi.org/10.62480/tjms.2022.vol4.pp4-11

References

  1. Rosen PP, ed. Chapter 2. Abnormalities of mammary growth and development. In: Rosen’s Breast Pathology, Second Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:23–27.
  2. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990;12:228–240.
  3. Hutchinson WB, Thomas DB, Hamlin WB et al. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst 1980;65:13–20.
  4. Guray M, Sahin AA; Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006 May;11(5):435-49. [abstract]
  5. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998;122:1053–1055.
  6. Donegan WL. Common benign conditions of the breast. In: Donegan WL, Spratt JS, eds. Cancer of the Breast, Fifth Edition. St. Louis, MO: Saunders, 2002:67–110.
  7. Sarnelli R, Squartini F. Fibrocystic condition and “at risk” lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 1991;18:271–279.
  8. Foxman B, D’Arcy H, Gillespie B et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002;155:103–114.
  9. Kooistra BW, Wauters C, van de Ven S, et al; The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol. 2009 Jun;35(6):573-7. Epub 2008 Nov 4. [abstract].
  10. Guray M, Sahin AA; Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006 May;11(5):435-49. [abstract]
  11. Bartow SA, Pathak DR, Black WC et al. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987;60:2751–2760.
  12. Shaaban AM, Sloane JP, West CS et al. Histopathologic types of benign breast lesions and risk of breast cancer. Am J Surg Pathol 2002;26: 421–430.
  13. Rahal RM, de Freitas-Junior R, Paulinelli RR; Risk factors for duct ectasia. Breast J. 2005 Jul-Aug;11(4):262-5. [abstract].
  14. West KE, Wojcik EM, Dougherty TA, et al; Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. Am J Surg. 2006 Jan;191(1):57-60. [abstract]
  15. Kamal RM, Hamed ST, Salem DS; Classification of inflammatory breast disorders and step by step diagnosis. Breast J. 2009 Jul-Aug;15(4):367-80. Epub 2009 May 22. [abstract].

Most read articles by the same author(s)